These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21786003)

  • 1. [Livedoid vasculopathy. Pathogenesis, diagnosis and treatment of cutaneous infarction].
    Goerge T
    Hautarzt; 2011 Aug; 62(8):627-34; quiz 635. PubMed ID: 21786003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Livedoid vasculopathy - current aspects of diagnosis and treatment of cutaneous infarction.
    Kerk N; Goerge T
    J Dtsch Dermatol Ges; 2013 May; 11(5):407-10. PubMed ID: 23437985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Livedoid vasculopathy - a thrombotic disease.
    Kerk N; Goerge T
    Vasa; 2013 Sep; 42(5):317-22. PubMed ID: 23989066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Livedoid vasculopathy: an intringuing cutaneous disease.
    Criado PR; Rivitti EA; Sotto MN; Valente NY; Aoki V; Carvalho JF; Vasconcellos C
    An Bras Dermatol; 2011; 86(5):961-77. PubMed ID: 22147037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unilateral livedoid vasculopathy associated with involutional phase of cutaneous infantile hemangioma: the connection to coagulation disorders.
    Criado PR; Alavi A; Halpern I; Sotto MN; Kirsner RS
    Int J Low Extrem Wounds; 2013 Dec; 12(4):306-9. PubMed ID: 24043683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrophie blanche: is it associated with venous disease or livedoid vasculopathy?
    Alavi A; Hafner J; Dutz JP; Mayer D; Sibbald RG; Criado PR; Senet P; Callen JP; Phillips TJ; Romanelli M; Kirsner RS
    Adv Skin Wound Care; 2014 Nov; 27(11):518-24; quiz 525-6. PubMed ID: 25325229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Livedoid Vasculopathy Presenting in a Patient With Sickle Cell Disease.
    Reagin H; Marks E; Weis S; Susa J
    Am J Dermatopathol; 2018 Sep; 40(9):682-685. PubMed ID: 29533274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative Results, Positive Outcome: A Case of Primary Livedoid Vasculopathy With an Elusive Laboratory Workup.
    Al-Obaidi AD; Sabeeh SK; Mohammed MJ; Othman A; Algburi YA; Hashim HT; Alhatemi AQM; Al Hilali Z; Al-Attabi BRT; Al-Awad A
    J Investig Med High Impact Case Rep; 2024; 12():23247096241266090. PubMed ID: 39068597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin.
    Osada S; Kimura Y; Kawana S
    J Dermatol; 2010 Jan; 37(1):98-101. PubMed ID: 20175830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Livedoid vasculopathy as a coagulation disorder.
    Criado PR; Rivitti EA; Sotto MN; de Carvalho JF
    Autoimmun Rev; 2011 Apr; 10(6):353-60. PubMed ID: 21184847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case of livedoid vasculopathy with extensive dermal capillary thrombi.
    Shimizu A; Tamura A; Yamanaka M; Amano H; Nagai Y; Ishikawa O
    J Dermatol; 2010 Jan; 37(1):94-7. PubMed ID: 20175829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of livedoid vasculopathy focused on direct oral anticoagulants (DOACs): four case reports successfully treated with rivaroxaban.
    Franco Marques G; Criado PR; Alves Batista Morita TC; Cajas García MS
    Int J Dermatol; 2018 Jun; 57(6):732-741. PubMed ID: 29663354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rivaroxaban prevents painful cutaneous infarctions in livedoid vasculopathy.
    Kerk N; Drabik A; Luger TA; Schneider SW; Goerge T
    Br J Dermatol; 2013 Apr; 168(4):898-9. PubMed ID: 23106384
    [No Abstract]   [Full Text] [Related]  

  • 14. Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach.
    Alavi A; Hafner J; Dutz JP; Mayer D; Sibbald RG; Criado PR; Senet P; Callen JP; Phillips TJ; Romanelli M; Kirsner RS
    J Am Acad Dermatol; 2013 Dec; 69(6):1033-1042.e1. PubMed ID: 24028907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vasculitis and vasculopathy].
    Marković A
    Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of new low-dose oral anticoagulants in recalcitrant livedoid vasculopathy.
    Furukawa F; Mizawa M; Makino T; Shimizu T
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28739563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recurrent leg ulcers due to livedoid vasculopathy: successful treatment with low-molecular-weight heparin].
    Becker A; Stoffels-Weindorf M; Schimming T; Dissemond J
    Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1458-62. PubMed ID: 23821447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of livedoid vasculopathy to rivaroxaban.
    Winchester DS; Drage LA; Davis MD
    Br J Dermatol; 2015 Apr; 172(4):1148-50. PubMed ID: 25255997
    [No Abstract]   [Full Text] [Related]  

  • 19. Livedoid vasculopathy - A diagnostic and therapeutic challenge.
    Burg MR; Mitschang C; Goerge T; Schneider SW
    Front Med (Lausanne); 2022; 9():1012178. PubMed ID: 36262273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Livedoid vasculopathy associated with sickle cell trait: significant improvement on aspirin treatment.
    El Khoury J; Taher A; Kurban M; Kibbi AG; Abbas O
    Int Wound J; 2012 Jun; 9(3):344-7. PubMed ID: 22044499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.